Diarrhea 11, malabsorptive, congenital

disease
On this page

Also known as DIAR11Intractable Diarrhoea of Infancy Syndrome

Summary

Diarrhea 11, malabsorptive, congenital (MONDO:0032857) is a disease with 1 cohort gene.

At a glance

  • Cohort genes: 1
  • ClinVar variants: 6

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

FieldValue
Canonical namediarrhea 11, malabsorptive, congenital
Mondo IDMONDO:0032857
OMIM618662
UMLSC5231449
MedGen1684754
Is cancer (heuristic)no

Also known as: DIAR11 · Intractable Diarrhoea of Infancy Syndrome

Data availability: 6 ClinVar variants.

Disease family

Classification path: disease › human disease › disease by body system or component › digestive system disorderdiarrheal diseasecongenital diarrheadiarrhea 11, malabsorptive, congenital

Related subtypes (11): congenital malabsorptive diarrhea 4, congenital diarrhea 6, congenital diarrhea 7 with exudative enteropathy, congenital sodium diarrhea, diarrhea 12, with microvillus atrophy, diarrhea 9, diarrhea 10, protein-losing enteropathy type, congenital secretory diarrhea, diarrhea 13, diarrhea 14, congenital, diarrhea 15, congenital

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

ClinVar germline variants

6 retrieved; paginated sample, class counts are floors:

3 pathogenic, 2 likely pathogenic, 1 uncertain significance

ClinVarVariant (HGVS)GeneClassificationReview
694448NC_000016.10:g.1425365_1432378delLOC115253417Pathogenicno assertion criteria provided
694449NC_000016.10:g.1430850_1433951delLOC115253417Pathogenicno assertion criteria provided
3255349NM_001365310.2(PERCC1):c.390C>G (p.Tyr130Ter)PERCC1Pathogeniccriteria provided, single submitter
2582632NM_001365310.2(PERCC1):c.348C>G (p.Tyr116Ter)PERCC1Likely pathogeniccriteria provided, multiple submitters, no conflicts
4073527NM_001365310.2(PERCC1):c.188C>G (p.Ser63Ter)PERCC1Likely pathogeniccriteria provided, single submitter
3235249NM_001365310.2(PERCC1):c.541G>A (p.Gly181Arg)PERCC1Uncertain significancecriteria provided, single submitter

Genes & proteins

Mendelian disease overlap and somatic drivers

GenCC: 0 · Orphanet: 1 · OMIM-shared: 0 · Dual-evidence (GWAS+Mendelian): 0

Orphanet rare-disease linkage (cohort genes)

GeneOrphanet IDRare disease
PERCC1Orphanet:714490PERCC1-related congenital intractable malabsorptive diarrhea

Cohort genes → proteins

1 cohort genes, 1 distinct canonical proteins.

Evidence partition

SubsetGenes
multi_evidence1

Cohort genes (full)

SymbolHGNCEnsemblUniProtNameEvidence
PERCC1HGNC:52293ENSG00000284395A0A1W2PR82Protein PERCC1clinvar

Cohort function summary

Lead sentence per gene, UniProt-curated.

SymbolProtein nameFunction (lead sentence)
PERCC1Protein PERCC1Plays a critical role in intestinal function.

Protein-family classification

Druggable: 0 · Difficult: 0 · Unknown: 1 · Druggable fraction: 0.0

Family distribution

Cohort families vs a genome-wide background (hypergeometric, BH-FDR; fold = observed/expected). Counts kept; sorted by enrichment, so the catch-all Other/Unknown bucket no longer leads.

FamilyGenesFoldFDR
Other/Unknown11.8×0.558

Per-gene assignment

SymbolFamilyDruggable?ECInterPro (top 3)
PERCC1Other/UnknownnoTEADIR3_omega_loop

Expression context

Cohort genes with no expression data: 0.

Breadth distribution (Bgee present_calls)

BucketGenes
narrow (1-5 tissues)0
moderate (6-20)0
broad (>20)1
unknown0

Top tissues across cohort

TissueCohort genes
body of stomach1
duodenum1
stomach1

Per-gene tissue summary (top 30)

SymbolBgee breadthFANTOM5 breadthSCXATop tissues
PERCC140tissue_specificyesduodenum, body of stomach, stomach

Protein interactions among cohort

Intra-cohort edges: 0.

Hub genes (top 10 by interactor count)

SymbolInteractor count
PERCC152

Structural data

PDB: 0 · AlphaFold-only: 1 · No structure: 0

AlphaFold-only cohort genes (top 30 by pLDDT)

SymbolUniProtpLDDT
PERCC1A0A1W2PR8264.66

Function

Pathway analysis

Distinct Reactome pathways touched by cohort: 0. Enrichment computed across 1 evidence-associated genes (0 with Reactome annotation).

GO biological processes by enrichment

Over-representation of cohort genes vs the genome-wide background (hypergeometric test, Benjamini-Hochberg FDR; fold = observed/expected over 1 annotated cohort genes). Counts and members are kept as ground-truth; sorted by enrichment.

GO termCohort genesFoldFDRSample cohort genes
enteroendocrine cell differentiation14213.0×5e-04PERCC1
digestive tract morphogenesis1991.3×0.001PERCC1

Therapeutics

Drug target analysis

Approved (phase 4): 0 · Phase ≥3: 0 · Phased (≥1): 0 · Undrugged: 1

Druggability breadth: 0 of 1 evidence-associated genes (0%) have a ChEMBL target (buckets above are over the deeply-mined display cohort).

Top cohort targets by molecule count

SymbolMoleculesMax phase
PERCC100

Bioactivity and enzyme data

Enzyme cohort genes (≥1 EC): 0.

Pharmacogenomics

Cohort genes with a PharmGKB record: 1; with CPIC/DPWG dosing guidelines: 0.

No cohort gene has a CPIC/DPWG genotype-guided dosing guideline (PharmGKB).

Chemical tractability of cohort targets

0 approved/phased compounds have measured bioactivity against a cohort gene (and aren’t yet in disease-level trials). This is a research / tractability signal, NOT a therapeutic recommendation — a bioactivity row often reflects off-target or screening binding (e.g. promiscuous kinase inhibitors against a cohort kinase), implying no disease mechanism.

Druggability pyramid

Cohort genes binned by druggability tier (high → low):

TierDefinitionGenesSymbols
AApproved (phase 4 drug)0
BPhased (≥1) drug, not yet approved0
CDruggable family + PDB, no drug0
DDruggable family + AlphaFold only, no drug0
EDifficult family or no structure, no drug1PERCC1

Undrugged target profiles

1 cohort genes are undrugged. Ranked by ‘starting-point quality’ (assay depth + drugged-partner adjacency).

SymbolChEMBL assaysDrugged partners (top 3)
PERCC10

Clinical trials & evidence

Clinical trials

Clinical trials: 0.